Supramolecular Assemblies of Heterogeneous Mesoporous Silica Nanoparticles to Co-Deliver Antimicrobial Peptides and Antibiotics for Synergistic Eradication of Pathogenic Biofilms.

Qilin Yu,Tian Deng,Fang-Chu Lin,Bing Zhang,Jeffrey I Zink
DOI: https://doi.org/10.1021/acsnano.0c01336
IF: 17.1
2020-01-01
ACS Nano
Abstract:Pathogenic biofilms protected by extracellular polymeric substances frequently compromise the efficiency of antibacterial drugs and severely threaten human health. In this study, we designed a multi-stimuli-responsive magnetic supramolecular nanoplatform to co-deliver large and low molecular weight drugs for synergistic eradication of pathogenic biofilms. This co-delivery platform was composed of mesoporous silica nanoparticles (MSNs) with large pores (MSNLP) capped by β-cyclodextrin (β-CD)-modified polyethyleneimine (PEICD) and adamantane (ADA)-decorated MSNs containing a magnetic core (MagNP@MSNA) capped by cucurbit[6]uril (CB[6]). The host MSNs (H, MSNLP@PEICD) and the guest MSNs (G, MagNP@MSNA-CB[6]) spontaneously form co-assemblies (H+G), based on the host-guest interactions between β-CD and ADA. Under the stimulus of pathogen cells together with heating by an alternating magnetic field (AMF), the supramolecular co-assemblies released both the large molecular weight antimicrobial peptide melittin (MEL) and the low molecular weight antibiotic ofloxacin (OFL) with high efficiency. As compared to free drugs (MEL and OFL) or unattached MSNs (H or G), the drug-loading H+G co-assemblies (H-MEL+G-OFL) exhibited much higher capacity for biofilm eradication, thoroughly remov-ing biofilm biomass and killing the pathogenic cells, and displaying no obvious toxicity to mammalian cells. This strong anti-biofilm capacity was severely decreased when the host and guest components were prevented from co-assembling but ad-ministered simultaneously, revealing the critical role of the supramolecular assembly in biofilm removal. Moreover, an in vivo implantation model showed that the co-assemblies eradicated the pathogenic biofilms from the implants, preventing host tissue damage and inflammation. Therefore, the co-delivering and multi-stimuli-responsive nanocarriers could over-come the anti-infection difficulties during treatment of infections because of protective biofilms.
What problem does this paper attempt to address?